Lupin Ltd.

NSE: LUPIN | BSE: 500257 | ISIN: INE326A01037 | Industry: Pharmaceuticals
| Mid-range Performer
1999.6000 -23.60 (-1.17%)
NSE Jun 13, 2025 15:31 PM
Volume: 475.9K
 

logo
Lupin Ltd.
24 Apr 2024
1999.60
-1.17%
Axis Direct
Niche product approvals and a strong pipeline of new drugs could drive Revenue/PAT CAGR by 10%/19.5% over FY24E-FY26E. We maintain our BUY rating with a Target Price of Rs 1,770/share.
Lupin Ltd. is trading below all available SMAs
More from Lupin Ltd.
Recommended